© 2020 MJH Life Sciences and Medical Economics. All rights reserved.
© 2020 MJH Life Sciences™ and Medical Economics. All rights reserved.
October 16, 2020
In an open letter, CEO Albert Bouria sought to give clarity to the drug’s development timeline.
September 14, 2020
The trial had been halted due to a side-effect in an English patient.
September 08, 2020
The pledge seeks to assuage fears that the Trump administration will rush a vaccine into production for political purposes.
September 02, 2020
In a letter, the agency pushes states to fast-track permitting and licensing for possible distribution sites.
August 21, 2020
The ACP says that staying up to date on vaccinations is more important than ever.
July 27, 2020
A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.
July 22, 2020
The deal is for the companies to supply up to 600 million doses of a MRNA-based vaccine candidate.
July 20, 2020
The candidate is a joint effort of Oxford University and AstraZeneca.
July 15, 2020
In a 45-person phase one clinical trial the vaccine subjects who received the vaccine candidate showed high neutralizing antibody responses.
September 17, 2019
For people who love cats but are allergic to them, relief may be on the horizon-and cats, rather than humans, would be the ones to be vaccinated.